Vericel

VCEL NASDAQ
15.71
-0.07
-0.44%
After Hours: 15.71 0 0.00% 16:51 05/22 EDT
Open
15.78
Prev Close
15.78
High
15.99
Low
15.50
Volume
450.76K
Avg Vol (3M)
666.77K
52 Week High
21.01
52 Week Low
8.95
% Turnover
1.03%
Market Cap
689.85M
1D
5D
1M
3M
1Y
5Y

Comments

No Data

Related

Webull offers Vericel VCEL stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Vericel Corporation, formerly Aastrom Biosciences, Inc., is a commercial-stage biopharmaceutical company dedicated to the identification, development and commercialization of therapies that enable the body to repair and regenerate damaged tissues and organs to restore normal structure and function. The Company operates through the research, product development, manufacture and distribution of patient-specific, expanded cellular therapies for use in the treatment of specific diseases segment. Its autologous cell therapy products include Carticel (autologous cultured chondrocytes), which is an autologous chondrocyte implant for the treatment of cartilage defects in the knee, and Epicel (cultured epidermal autografts), which is a permanent skin replacement for the treatment of patients with deep-dermal or full-thickness burns. The Company is developing MACI, which is a third-generation autologous chondrocyte implant and ixmyelocel-T, which is a patient-specific multicellular therapy.
MORE >

Recently

Name
Price
%Change